Total IGF-I R/IGF1R ELISA DYC305-2 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemTotal IGF-I R/IGF1R ELISA
CompanyR&D Systems, a Bio-Techne Brand
Price $495.00Supplier Page View Company Product Page
Catalog NumberDYC305-2
Quantity1 Kit (for 2 Plates) (also 1 Kit (for 5 Plates))
ApplicationsELISA
Detection Range156.00 - 10000 pg/mL
ReactivityHuman
Detection TargetIGF-I R/IGF1R
Assay Time4 hours 40 mins (after plate preparation)
StorageStore the unopened product at 2 - 8 °C. Do not use past expiration date
NCBI Full Gene Nameinsulin like growth factor 1 receptor
NCBI Gene AliasesCD221, IGFIR, IGFR, JTK13

Specifications/Features

Available conjugates: Sizes Available: 1 Kit (for 2 Plates) (also 1 Kit (for 5 Plates))

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trialThe Lancet OncologyFebruary 1, 2014Arun Rajan, Corey A. Carter, Arlene Berman, Liang Cao, Ronan J. Kelly, Anish Thomas, Sean Khozin, Ariel Lopez Chavez, Isabella Bergagnini, Barbara Scepura, et al.as previously described.10 The test reagents (antibodies pairs) for both IGF-1 and IGF-1R (DY291 and DYC305-2 respectively) were obtained from R&D Systems. The assay for phospho-AKT analysis was acquired from Meso-Scale

(2) Improvement of human keratinocyte migration by a redox active bioelectric dressingPloS oneJanuary 1, 2014Banerjee J, Das Ghatak P, Roy S, Khanna S, Sequin EK, Bellman K, Dickinson BC, Suri P, Subramaniam VV, Chang CJ, et al.

(3) Activated phosphoinositide 3-kinase/AKT signaling confers resistance to trastuzumab but not lapatinibMolecular cancer therapeuticsJune 1, 2010O'Brien NA, Browne BC, Chow L, Wang Y, Ginther C, Arboleda J, Duffy MJ, Crown J, O'Donovan N, Slamon DJ.

(4) Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibodyCancer researchOctober 1, 2008Cao L, Yu Y, Darko I, Currier D, Mayeenuddin LH, Wan X, Khanna C, Helman LJ.

(5) Insulin-like growth factor-I receptor blockade by a specific tyrosine kinase inhibitor for human gastrointestinal carcinomasMolecular cancer therapeuticsJune 1, 2008Piao W, Wang Y, Adachi Y, Yamamoto H, Li R, Imsumran A, Li H, Maehata T, Ii M, Arimura Y, et al.

Be the First to Write a Review!

Total IGF-I R/IGF1R ELISA

Total IGF-I R/IGF1R ELISA

Total IGF-I R/IGF1R ELISA

Total IGF-I R/IGF1R ELISA from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (5)

Reviews

Total IGF-I R/IGF1R ELISA from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map